AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9402453 — intervention group
Group type: COMPARATOR
Intervention: Manually delivered radiofrequency catheter ablation
Number of subjects: 69
Study 7587605 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudo treatment
Number of subjects: 31
Study 7587605 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 31
Study 2146242 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin (single intramuscular injection)
Number of subjects: 55
Study 2146242 — intervention group
Group type: COMPARATOR
Intervention: 500 mg erythromycin base (five-day oral course, three times daily)
Number of subjects: 55
Study 2146242 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin
Number of subjects: 55
Study 657032 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aerosol spray containing neomycin sulfate, polymyxin B sulfate and zinc bacitracin
Number of subjects: 100
Study 657032 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 100
Study 31915035 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual intervention program (starting at 1 year CA)
Number of subjects: 100
Study 31915035 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment (control group starting at 2 years CA)
Number of subjects: 100
Study 30670238 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (n = 41), 90-minute sessions of physical, cognitive, or social activities twice weekly
Number of subjects: 83
Study 30670238 — intervention group
Group type: COMPARATOR
Intervention: Health education control group (n = 42)
Number of subjects: 83
Study 30670238 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (n = 41)
Number of subjects: 83
Study 28093370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat
Number of subjects: 22
Study 28093370 — intervention group
Group type: EXPERIMENTAL
Intervention: G-EO
Number of subjects: 22
Study 28093370 — intervention group
Group type: EXPERIMENTAL
Intervention: PBWSTT
Number of subjects: 22
Study 25749543 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone sodium phosphate (DSP) cream applied to the right ear for 15 days
Number of subjects: 32
Study 25749543 — intervention group
Group type: COMPARATOR
Intervention: Placebo-water in oil emulsion type cream applied to the left ear for 15 days
Number of subjects: 32
Study 24535377 — intervention group
Group type: COMPARATOR
Intervention: β-blocker therapy
Number of subjects: 14
Study 24535377 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine therapy
Number of subjects: 14
Study 22763622 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized psychosocial stress procedure (Trier Social Stress Test)
Number of subjects: 71
Study 22763622 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 71
Study 20593433 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary health insurance program
Number of subjects: 0
Study 18274218 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-test condition
Number of subjects: 0
Study 18274218 — intervention group
Group type: COMPARATOR
Intervention: One-test condition
Number of subjects: 0
Study 18274218 — intervention group
Group type: EXPERIMENTAL
Intervention: Speeded-response key-pressing tasks
Number of subjects: 0
Study 18274218 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential-timing tasks
Number of subjects: 0
Study 15807926 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine agents like aromatase inhibitors and luteinizing hormone-releasing hormone agonists
Number of subjects: 0
Study 15807926 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent bisphosphonates
Number of subjects: 0
Study 11851906 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐alpha2a, ribavirin and amantadine
Number of subjects: 2
Study 10447136 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants of mothers who smoked and consumed alcohol during pregnancy
Number of subjects: 40
Study 10447136 — intervention group
Group type: COMPARATOR
Intervention: Infants of mothers who abstained from both alcohol and smoking
Number of subjects: 40
Study 8690815 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg twice daily of befloxatone
Number of subjects: 12
Study 8690815 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg once daily of befloxatone
Number of subjects: 12
Study 8690815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2071841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability training
Number of subjects: 116
Study 2071841 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended retest practice
Number of subjects: 116
Study 6862626 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 40
Study 6862626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30554263 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapsed ependymoma (n = 13)
Number of subjects: 44
Study 30554263 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-relapsing ependymoma (n = 16)
Number of subjects: 44
Study 27888435 — intervention group
Group type: EXPERIMENTAL
Intervention: Ma-Pi2 macrobiotic diet
Number of subjects: 40
Study 27888435 — intervention group
Group type: COMPARATOR
Intervention: Control diet based on dietary guidelines for type 2 diabetes
Number of subjects: 40
Study 25751300 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-Lipoic Acid (ALA) 1200 mg/day for 8 weeks
Number of subjects: 70
Study 25751300 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 70
Study 24121698 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawaiian‐based, self‐management intervention for reducing blood pressure and stress
Number of subjects: 0
Study 20951527 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-axis approach to ultrasound-guided peripheral intravenous access (USGPIV)
Number of subjects: 40
Study 20951527 — intervention group
Group type: COMPARATOR
Intervention: Long-axis approach to ultrasound-guided peripheral intravenous access (USGPIV)
Number of subjects: 40
Study 20027350 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaferon (pediatric formulation)
Number of subjects: 0
Study 17099514 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mL/kg 7.5% NaCl
Number of subjects: 15
Study 17099514 — intervention group
Group type: COMPARATOR
Intervention: 4 mL/kg 0.9% NaCl
Number of subjects: 15
Study 17099514 — intervention group
Group type: COMPARATOR
Intervention: 32 mL/kg 0.9% NaCl
Number of subjects: 15
Study 14715354 — intervention group
Group type: EXPERIMENTAL
Intervention: Strenuous aerobic activity
Number of subjects: 0
Study 14715354 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 11758304 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitored polysomnography (TMpsg)
Number of subjects: 99
Study 11758304 — intervention group
Group type: COMPARATOR
Intervention: Home unattended polysomnography (Hpsg)
Number of subjects: 99
Study 1407911 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management plus antimicrobial therapy (intravenous ampicillin, gentamicin, and clindamycin for 24 hours, followed by amoxicillin plus clavulanic acid orally for 7 days.
Number of subjects: 94
Study 1407911 — intervention group
Group type: COMPARATOR
Intervention: Expectant management alone
Number of subjects: 94
Study 1407911 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management plus antimicrobial therapy
Number of subjects: 94
Study 3899506 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD insertion immediately after abortion
Number of subjects: 0
Study 3899506 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD insertion (Nova T)
Number of subjects: 0
Study 3899506 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD insertion (Multiload 250)
Number of subjects: 0
Study 3899506 — intervention group
Group type: EXPERIMENTAL
Intervention: IUD insertion (both types)
Number of subjects: 0
Study 3899506 — intervention group
Group type: COMPARATOR
Intervention: Oral contraception
Number of subjects: 0
Study 30253776 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercises embedded in physical education classes (15-30 min, 2x per week) plus monthly motivational lessons
Number of subjects: 695
Study 30253776 — intervention group
Group type: COMPARATOR
Intervention: Control group following usual curriculum
Number of subjects: 695
Study 30253776 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercises plus motivational lessons
Number of subjects: 695
Study 27107680 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Cancer Care: A Personal Guide (MCC)
Number of subjects: 60
Study 27107680 — intervention group
Group type: COMPARATOR
Intervention: Symptom Management Toolkit
Number of subjects: 60
Study 24958355 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth device (electronic pill box)
Number of subjects: 60
Study 24958355 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone app (m-health intervention)
Number of subjects: 60
Study 24958355 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders (from both interventions)
Number of subjects: 60
Study 24958355 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive medication reminder devices (silent)
Number of subjects: 60
Study 24958355 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 60
Study 22837068 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Group (SG) with prone-positioning support and inflatable device
Number of subjects: 40
Study 22837068 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) without support
Number of subjects: 40
Study 20179697 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulfate (SPS)
Number of subjects: 367
Study 20179697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 19189674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil S3 Bond
Number of subjects: 42
Study 19189674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Futurabond NR
Number of subjects: 42
Study 19189674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil SE Bond at priming
Number of subjects: 42
Study 19189674 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic agitation during application of Clearfil SE Bond at bonding
Number of subjects: 42
Study 19189674 — intervention group
Group type: COMPARATOR
Intervention: Control group with Clearfil S3 Bond
Number of subjects: 42
Study 19189674 — intervention group
Group type: COMPARATOR
Intervention: Control group with Futurabond NR
Number of subjects: 42
Study 19189674 — intervention group
Group type: COMPARATOR
Intervention: Control group with Clearfil SE Bond
Number of subjects: 42
Study 16157523 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (3 monthly courses)
Number of subjects: 23
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre-based exercise
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy for overcoming barriers
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Decisional balance
Number of subjects: 115
Study 14614794 — intervention group
Group type: EXPERIMENTAL
Intervention: Action to maintenance
Number of subjects: 115
Study 10960225 — intervention group
Group type: EXPERIMENTAL
Intervention: TNO Test
Number of subjects: 115
Study 10960225 — intervention group
Group type: COMPARATOR
Intervention: Titmus Stereotest Circles
Number of subjects: 115
Study 8889084 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care manual for bulimia nervosa, duration: 8 weeks
Number of subjects: 100
Study 1802636 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg elemental iron daily)
Number of subjects: 207
Study 1802636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 4091151 — intervention group
Group type: EXPERIMENTAL
Intervention: VMS supplying the USRDA of all vitamins, zinc, iron, iodine, copper, and 60% of the USRDA of calcium, 50% of magnesium and 45% of phosphorus, consumed for 77 days.
Number of subjects: 42
Study 4091151 — intervention group
Group type: COMPARATOR
Intervention: Placebo, consumed for 77 days.
Number of subjects: 42
Study 30077119 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronised progesterone (MP)
Number of subjects: 141
Study 30077119 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone (DYD)
Number of subjects: 141
Study 30077119 — intervention group
Group type: EXPERIMENTAL
Intervention: Low serum progesterone group
Number of subjects: 141
Study 26847007 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapist‐guided aerobic exercise
Number of subjects: 13
Study 24903469 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for dementia using the Memory Impairment Screen Telephone version
Number of subjects: 4000
Study 24903469 — intervention group
Group type: COMPARATOR
Intervention: No screening for dementia
Number of subjects: 4000
Study 21846425 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R) programme
Number of subjects: 84
Study 21846425 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning and Rehabilitation (R&R) programme (completers)
Number of subjects: 84
Study 21846425 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 84
Study 21516496 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment + Tamsulosin (TAM)
Number of subjects: 65
Study 21516496 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment + Placebo
Number of subjects: 65
Study 17868403 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 180
Study 17868403 — intervention group
Group type: COMPARATOR
Intervention: Glyceryltrinitrate (GTN)
Number of subjects: 180
Study 16550369 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation
Number of subjects: 31
Study 16550369 — intervention group
Group type: COMPARATOR
Intervention: Intermittent mandatory ventilation
Number of subjects: 31
Study 12890302 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (100 mg b.i.d.)
Number of subjects: 24
Study 12890302 — intervention group
Group type: COMPARATOR
Intervention: Placebo (bid)
Number of subjects: 24
Study 10733058 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% body weight vest
Number of subjects: 62
Study 10733058 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% body weight vest
Number of subjects: 62
Study 10733058 — intervention group
Group type: COMPARATOR
Intervention: No vest (control)
Number of subjects: 62
Study 8606066 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 ng of Salmonella abortus equi endotoxin per kg of body weight administered intravenously at 0900 h
Number of subjects: 0
Study 8606066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1533606 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg)
Number of subjects: 18
Study 1533606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 1533606 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (before ingestion of isradipine or placebo)
Number of subjects: 18
Study 1533606 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting condition
Number of subjects: 18
Study 6505988 — intervention group
Group type: EXPERIMENTAL
Intervention: Encouragement during walking tests
Number of subjects: 43
Study 30260681 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced sonification (tremolo)
Number of subjects: 0
Study 30260681 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced sonification (tremolo plus brightness)
Number of subjects: 0
Study 30260681 — intervention group
Group type: COMPARATOR
Intervention: Conventional sonification
Number of subjects: 0
Study 29629988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral blood flow measured at a mean arterial pressure target of 65 mm Hg in septic patients
Number of subjects: 22
Study 29629988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral blood flow measured at a mean arterial pressure target of greater than or equal to 75 mm Hg in septic patients
Number of subjects: 22
Study 29629988 — intervention group
Group type: COMPARATOR
Intervention: Cerebral blood flow measured without sedation in control subjects
Number of subjects: 22
Study 29629988 — intervention group
Group type: COMPARATOR
Intervention: Cerebral blood flow measured with sedation in control subjects
Number of subjects: 22
Study 29629988 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral blood flow in sedated septic patients (mean arterial pressure target 65 mm Hg)
Number of subjects: 22
Study 26657819 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotype threat condition
Number of subjects: 55
Study 26657819 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 55
Study 25122647 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women consuming 57 μg of dietary biotin/d
Number of subjects: 75
Study 25122647 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactating women consuming 57 μg of dietary biotin/d
Number of subjects: 75
Study 25122647 — intervention group
Group type: COMPARATOR
Intervention: Control women
Number of subjects: 75
Study 23095631 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 275
Study 23095631 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical suturing or stapling
Number of subjects: 275
Study 20171481 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg morphine
Number of subjects: 48
Study 20171481 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg morphine
Number of subjects: 48
Study 20171481 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (Carbostesin)
Number of subjects: 48
Study 20171481 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline solution (placebo)
Number of subjects: 48
Study 17926825 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study 16221550 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini‐ECC
Number of subjects: 136
Study 16221550 — intervention group
Group type: COMPARATOR
Intervention: CPB
Number of subjects: 136
Study 12710841 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (Seredrin)
Number of subjects: 0
Study 12710841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10022631 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula UBT with 270 ml of mixed formula meal (1 Kcal/ml)
Number of subjects: 115
Study 10022631 — intervention group
Group type: COMPARATOR
Intervention: Water UBT with equivalent amount of tap water
Number of subjects: 115
Study 10022631 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPA pretreatment (500 mg given 30 min before [13C]-urea load)
Number of subjects: 115
Study 8528429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost estimates for the intervention group
Number of subjects: 0
Study 8528429 — intervention group
Group type: COMPARATOR
Intervention: Baseline costs for the control group
Number of subjects: 0
Study 2272718 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg acenocoumarol in combination with cimetidine
Number of subjects: 9
Study 2272718 — intervention group
Group type: COMPARATOR
Intervention: 10 mg acenocoumarol in combination with placebo
Number of subjects: 9
Study 2272718 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg acenocoumarol after one week pretreatment with pentobarbitone
Number of subjects: 9
Study 7375236 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 44
Study 7375236 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 44
Study 7375236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 31786651 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg
Number of subjects: 20
Study 31786651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30384775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 252
Study 30384775 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalytic therapy (PAT)
Number of subjects: 252
Study 27803983 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-handed jaw thrust
Number of subjects: 60
Study 27803983 — intervention group
Group type: COMPARATOR
Intervention: Single-handed chin lift
Number of subjects: 60
Study 25909408 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA
Number of subjects: 1032
Study 25909408 — intervention group
Group type: COMPARATOR
Intervention: no-TXA
Number of subjects: 1032
Study 23879213 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral oxycodone prescribed, tailored dosing regimen; measured urine concentration 10 to 14 days after starting treatment.
Number of subjects: 20
Study 23879213 — intervention group
Group type: EXPERIMENTAL
Intervention: Model for predicting oxycodone in urine.
Number of subjects: 20
Study 21873632 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg daily)
Number of subjects: 291
Study 21873632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study 19729161 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 126
Study 19729161 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ovarian diathermy (LOD)
Number of subjects: 126
Study 16426958 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-enriched beverage
Number of subjects: 869
Study 16426958 — intervention group
Group type: COMPARATOR
Intervention: Placebo without added micronutrients
Number of subjects: 869
Study 12627177 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea without milk
Number of subjects: 10
Study 12627177 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea with milk
Number of subjects: 10
Study 12627177 — intervention group
Group type: COMPARATOR
Intervention: Black tea (both brands)
Number of subjects: 10